Anti-Oxidant AD4 for MS Shows Promise
-
cheerleader
- Family Elder
- Posts: 5361
- Joined: Mon Sep 10, 2007 2:00 pm
- Location: southern California
Hey Schnittke-
The link didn't work...
is this the story?
Technology transfer company of the Hebrew University of Jerusalem, Yissum, licensed molecule called N-acetylcysteine amide (AD4) to Eucalyptus Ltd.
The molecule is an antioxidant for the prevention and treatment of Parkinson’s, Alzheimer’s, multiple sclerosis and other neurodegenerative diseases that are linked to oxidative stress, and also has broader applications in biology. As per the agreement, the orally–available AD4 will be used for such purposes as the treatment of neurodegenerative diseases, among others.
The announcement reveals that Eucalyptus has worldwide exclusive rights to develop and commercialize the molecule. Yissum, Ramot and Mor Research Applications, will receive upfront and milestone payments based on development progress and royalties from sales of final products.
Professor Ashley Bush, CSO, Eucalyptus, commented: “I am very confident that AD4 will be therapeutically useful for several major neurological disorders, certain major psychiatric conditions as well as several other biological applications. I expect this to be a rapid development project.
best,
AC
The link didn't work...
is this the story?
Technology transfer company of the Hebrew University of Jerusalem, Yissum, licensed molecule called N-acetylcysteine amide (AD4) to Eucalyptus Ltd.
The molecule is an antioxidant for the prevention and treatment of Parkinson’s, Alzheimer’s, multiple sclerosis and other neurodegenerative diseases that are linked to oxidative stress, and also has broader applications in biology. As per the agreement, the orally–available AD4 will be used for such purposes as the treatment of neurodegenerative diseases, among others.
The announcement reveals that Eucalyptus has worldwide exclusive rights to develop and commercialize the molecule. Yissum, Ramot and Mor Research Applications, will receive upfront and milestone payments based on development progress and royalties from sales of final products.
Professor Ashley Bush, CSO, Eucalyptus, commented: “I am very confident that AD4 will be therapeutically useful for several major neurological disorders, certain major psychiatric conditions as well as several other biological applications. I expect this to be a rapid development project.
best,
AC
Wow, first post and it is a broken link. Sorry about that.
Yes, that is the article. Maybe this link will work.
http://tinyurl.com/2l4gae
Yes, that is the article. Maybe this link will work.
http://tinyurl.com/2l4gae
-
cheerleader
- Family Elder
- Posts: 5361
- Joined: Mon Sep 10, 2007 2:00 pm
- Location: southern California
-
TwistedHelix
- Family Elder
- Posts: 602
- Joined: Fri Mar 25, 2005 3:00 pm
- Location: Northamptonshire, England.
Here is additional information on AD-4. I found this article interesting because the research included the supplement NAC which many of us are currently taking.
http://www.ingentaconnect.com/content/b ... 3/art00004
Sharon
http://www.ingentaconnect.com/content/b ... 3/art00004
Sharon
Re: Anti-Oxidant AD4 for MS Shows Promise
There acutally wasn't any problem with the first link. A "preview.tinyurl" goes to the tinyurl site and displays the actual link so that people will have the opportunity to decide whether or not they wish to click on the link. By using tinyurl, it's possible to easily conceal a link that might take a web user to a compromised web page. However, by showing a preview of the url, it allows the user to decide if the linked page is secure or not before they click on it.TwistedHelix wrote:a brilliant first post, despite the minor technical hiccup!
Here's a description from the tinyurl site.
NHEPreview a TinyURL
Don't want to be instantly redirected to a TinyURL and instead want to see where it's going before going to the site? Not a problem with our preview feature.